ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE: IMMEDIATE AND LONG-TERM RESULTS

Cover Page
  • Authors: Khairutdinov E.R.1, Shugushev Z.K.2, Maksimkin D.A.3, Faibushevich A.G.4, Veretnik G.I.4, Arablinskii A.V.5, Tarichko Y.V.4
  • Affiliations:
    1. Central clinical hospital № 2 Russian railways, Moscow Botkin hospital, Moscow
    2. Central clinical hospital № 2 Russian railways, Moscow
    3. Peoples’ Friendship University of Russia, Moscow Central clinical hospital № 2 Russian railways, Moscow
    4. Peoples’ Friendship University of Russia, Moscow
    5. Botkin hospital, Moscow
  • Issue: Vol 67, No 7 (2012)
  • Pages: 8-14
  • Section: CARDIOLOGY: CURRENT ISSUES
  • URL: https://vestnikramn.spr-journal.ru/jour/article/view/282
  • DOI: https://doi.org/10.15690/vramn.v67i7.334
  • Cite item

Abstract


Immediate and long-term results of endovascular treatment of multivessel coronary artery disease by using different revascularization strategies were analyzed in 171 patients. Duration of follow up ranged from 12 to 18 months. Complete myocardium revascularization was performed in 63 patients, culprit vessel revascularization ― in 86 pts and incomplete revascularization ― in 22 pts. Results of this study showed that strategy of complete and culprit vessel revascularization in patients with multivessel coronary artery disease has comparable immediate and long-term results. Strategy of incomplete revascularization reduce immediate clinical success and lead to increased number of myocardial infarctions and needs of coronary artery bypass surgery in long-term follow-up period. 

 


E. R. Khairutdinov

Central clinical hospital № 2 Russian railways, Moscow
Botkin hospital, Moscow

Author for correspondence.
Email: eugkh@yandex.ru

Russian Federation врач-рентгенолог ГКБ им. С.П. Боткина, НУЗ ЦКБ № 2 им. Н.А. Семашко ОАО «РЖД» Адрес: 107150, Москва, ул. Лосиноостровская, д. 43 Тел.: (916) 830-49-64

Z. Kh. Shugushev

Central clinical hospital № 2 Russian railways, Moscow

Email: zaur937@mail.ru

Russian Federation кандидат медицинских наук, врач-хирург НУЗ ЦКБ № 2 им. Н.А. Семашко ОАО «РЖД» Адрес: 107150, Москва, ул. Лосиноостровская, д. 43 Тел.: (925) 772-61-99

D. A. Maksimkin

Peoples’ Friendship University of Russia, Moscow
Central clinical hospital № 2 Russian railways, Moscow

Email: danmed@bk.ru

Russian Federation кандидат медицинских наук, врач-хирург кафедры госпитальной хирургии с курсом детской хирургии медицинского факультета Российского университета дружбы народов Адрес: 117198, Москва, ул. Миклухо-Маклая, д. 8 Тел.: (916) 788-66-75

A. G. Faibushevich

Peoples’ Friendship University of Russia, Moscow

Email: eugkh@yandex.ru

Russian Federation кандидат медицинских наук, доцент кафедры госпитальной хирургии с курсом детской хирургии медицинского факультета Российского университета дружбы народов Адрес: 117198, Москва, ул. Миклухо-Маклая, д. 8 Тел.: (903) 259-38-10

G. I. Veretnik

Peoples’ Friendship University of Russia, Moscow

Email: eugkh@yandex.ru

Russian Federation кандидат медицинских наук, доцент кафедры госпитальной хирургии с курсом детской хирургии медицинского факультета Российского университета дружбы народов Адрес: 117198, Москва, ул. Миклухо-Маклая, д. 8 Тел.: (499) 966-95-60

A. V. Arablinskii

Botkin hospital, Moscow

Email: alexar-card@mail.ru

Russian Federation доктор медицинских наук, профессор ГКБ им. С.П. Боткина и кафедры терапии и подростковой медицины ГОУ ДПО РМАПО Росздрава Адрес: 125284, Москва, 2-й Боткинский пр-д, д. 5 Тел.: (495) 945-37-41

Yu. V. Tarichko

Peoples’ Friendship University of Russia, Moscow

Email: eugkh@yandex.ru

Russian Federation доктор медицинских наук, профессор кафедры госпитальной хирургии с курсом детской хирургии медицинского факультета Российского университета дружбы народов Адрес: 117198, Москва, ул. Миклухо-Маклая, д. 8 Тел.: (499) 966-95-60

  1. Silber S., Albertsson P., Aviles F.F. et al. Guidelines for percutaneous coronary interventions. Eur. Heart J. 2005; 26: 804−847.
  2. Topol E.J. Textbook of interventional cardiology. 2008. Р. 417−430.
  3. Belenkov Yu.N., Akchurin R.S., Savchenko A.P. et al. The results of coronary stenting and surgical treatment in patients with coronary artery disease with multivessel coronary disease. Kardiologiya – Cardiology. 2002; 5: 42−45.
  4. Ong A.T.L., Serruys P.W. Coronary artery bypass graft surgery versus percutaneous coronaryintervention. Circulation. 2006; 114: 249−255.
  5. Rodriguez A.E., Maree A.O., Mieres J. et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur. Heart J. 2007; 28: 2118–2125.
  6. Serruys P.W., Donohoe D.J., Wittebols K. et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur. Heart J. 2007; 28 (4): 433−442.
  7. Serruys P.W., Onuma Y., Garg S. et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5 (1): 50−56.
  8. Wijns W., Kolh P., Danchin N. et al. European Association for Percutaneous Cardiovascular Interventions. Guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS). Eur. Heart J. 2010; 31: 2501−2555.
  9. Hannan E.L., Racz M., Holmes D.R. et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006; 113; 2406−2412.
  10. van den Brand M.J.B.M., Rensing B.J.W.M., Morel M.M. et al. The effect of completeness of revascularization on event-free survival at one year in the arts trial. J. Am. Coll. Cardiol. 2002; 39: 559−564.
  11. Patil C.V., Nikolsky E., Boulos M. et al. Multivessel coronary artery disease: current revascularization strategies. Eur. Heart J. 2001; 22: 1183−1197.
  12. Chung C., Nakamura S., Tanaka K. et al. Effect of recanalization of CTO on global and regional LV function in pts with/without previous MI. Catheter Cardiovasc. Interv. 2003; 60: 368−374.
  13. Pijls N.H.J., Fearon W.F., Tonino P.A.L. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study. J. Am. Coll. Cardiol. 2010; 56: 177−184.
  14. Shaw L.J., Berman D.S., Maron D.J. et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008; 117: 1283−1291.
  15. Ambrose J.A., Winters S.L., Arrora R.R. et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J. Am. Coll. Cardiol. 1985; 6: 1233−1238.

Views

Abstract - 23

PDF (Russian) - 35

Cited-By


PlumX



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies